Annual Shareholders Equity
-$204.17 M
-$182.72 M-851.96%
December 31, 2023
Summary
- As of February 26, 2025, FGEN annual stockholders equity is -$204.17 million, with the most recent change of -$182.72 million (-851.96%) on December 31, 2023.
- During the last 3 years, FGEN annual shareholders equity has fallen by -$626.34 million (-148.36%).
- FGEN annual shareholders equity is now -138.63% below its all-time high of $528.47 million, reached on December 31, 2017.
Performance
FGEN Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
-$243.67 M
-$11.33 M-4.88%
September 30, 2024
Summary
- As of February 26, 2025, FGEN quarterly stockholders equity is -$243.67 million, with the most recent change of -$11.33 million (-4.88%) on September 30, 2024.
- Over the past year, FGEN quarterly shareholders equity has dropped by -$39.50 million (-19.35%).
- FGEN quarterly shareholders equity is now -138.74% below its all-time high of $629.03 million, reached on June 30, 2019.
Performance
FGEN Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
FGEN Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -852.0% | -19.4% |
| 3 y3 years | -148.4% | -19.4% |
| 5 y5 years | -140.1% | -19.4% |
FGEN Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -197.6% | at low | -216.5% | at low |
| 5 y | 5-year | -139.6% | at low | -147.2% | at low |
| alltime | all time | -138.6% | at low | -138.7% | at low |
FibroGen Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$243.67 M(+4.9%) |
| Jun 2024 | - | -$232.34 M(+1.8%) |
| Mar 2024 | - | -$228.12 M(+11.7%) |
| Dec 2023 | -$204.17 M(+852.0%) | -$204.17 M(+29.9%) |
| Sep 2023 | - | -$157.17 M(+53.7%) |
| Jun 2023 | - | -$102.27 M(+109.4%) |
| Mar 2023 | - | -$48.85 M(+127.8%) |
| Dec 2022 | -$21.45 M(-110.3%) | -$21.45 M(-181.5%) |
| Sep 2022 | - | $26.31 M(-74.7%) |
| Jun 2022 | - | $103.78 M(-34.3%) |
| Mar 2022 | - | $158.05 M(-24.4%) |
| Dec 2021 | $209.15 M(-50.5%) | $209.15 M(-35.8%) |
| Sep 2021 | - | $325.79 M(+25.0%) |
| Jun 2021 | - | $260.58 M(-29.8%) |
| Mar 2021 | - | $371.00 M(-12.1%) |
| Dec 2020 | $422.18 M(-18.2%) | $422.18 M(-6.5%) |
| Sep 2020 | - | $451.66 M(+14.1%) |
| Jun 2020 | - | $395.87 M(-13.6%) |
| Mar 2020 | - | $458.36 M(-11.2%) |
| Dec 2019 | $516.13 M | $516.13 M(-13.2%) |
| Sep 2019 | - | $594.45 M(-5.5%) |
| Jun 2019 | - | $629.03 M(+28.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $489.22 M(-3.9%) |
| Dec 2018 | $509.20 M(-3.6%) | $509.20 M(+8.0%) |
| Sep 2018 | - | $471.31 M(-4.9%) |
| Jun 2018 | - | $495.53 M(-0.8%) |
| Mar 2018 | - | $499.52 M(-5.5%) |
| Dec 2017 | $528.47 M(+239.1%) | $528.47 M(-7.5%) |
| Sep 2017 | - | $571.50 M(+148.4%) |
| Jun 2017 | - | $230.10 M(+74.7%) |
| Mar 2017 | - | $131.70 M(-15.5%) |
| Dec 2016 | $155.84 M(-12.2%) | $155.84 M(-12.6%) |
| Sep 2016 | - | $178.34 M(-7.6%) |
| Jun 2016 | - | $193.11 M(+23.0%) |
| Mar 2016 | - | $156.95 M(-11.6%) |
| Dec 2015 | $177.55 M(-19.8%) | $177.55 M(-18.3%) |
| Sep 2015 | - | $217.28 M(-14.3%) |
| Jun 2015 | - | $253.62 M(+37.4%) |
| Mar 2015 | - | $184.62 M(-16.6%) |
| Dec 2014 | $221.41 M(+177.7%) | $221.41 M(+170.8%) |
| Sep 2014 | - | $81.77 M(-27.0%) |
| Jun 2014 | - | $111.99 M(+40.5%) |
| Dec 2013 | $79.73 M(-15.6%) | $79.73 M |
| Dec 2012 | $94.48 M | - |
FAQ
- What is FibroGen annual stockholders equity?
- What is the all time high annual shareholders equity for FibroGen?
- What is FibroGen annual shareholders equity year-on-year change?
- What is FibroGen quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for FibroGen?
- What is FibroGen quarterly shareholders equity year-on-year change?
What is FibroGen annual stockholders equity?
The current annual shareholders equity of FGEN is -$204.17 M
What is the all time high annual shareholders equity for FibroGen?
FibroGen all-time high annual stockholders equity is $528.47 M
What is FibroGen annual shareholders equity year-on-year change?
Over the past year, FGEN annual stockholders equity has changed by -$182.72 M (-851.96%)
What is FibroGen quarterly stockholders equity?
The current quarterly shareholders equity of FGEN is -$243.67 M
What is the all time high quarterly shareholders equity for FibroGen?
FibroGen all-time high quarterly stockholders equity is $629.03 M
What is FibroGen quarterly shareholders equity year-on-year change?
Over the past year, FGEN quarterly stockholders equity has changed by -$39.50 M (-19.35%)